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A B S T R A C T
Objectives: To characterize the impact of PCB exposure on DNA methylation in peripheral blood leucocytes and
to evaluate the corresponding changes in relation to possible health eﬀects, with a focus on B-cell lymphoma.
Methods: We conducted an epigenome-wide association study on 611 adults free of diagnosed disease, living in
Italy and Sweden, in whom we also measured plasma concentrations of 6 PCB congeners, DDE and hexa-
chlorobenzene.
Results: We identiﬁed 650 CpG sites whose methylation correlates strongly (FDR < 0.01) with plasma con-
centrations of at least one PCB congener. Stronger eﬀects were observed in males and in Sweden. This epigenetic
exposure proﬁle shows extensive and highly statistically signiﬁcant overlaps with published proﬁles associated
with the risk of future B-cell chronic lymphocytic leukemia (CLL) as well as with clinical CLL (38 and 28 CpG
sites, respectively). For all these sites, the methylation changes were in the same direction for increasing ex-
posure and for higher disease risk or clinical disease status, suggesting an etiological link between exposure and
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CLL. Mediation analysis reinforced the suggestion of a causal link between exposure, changes in DNA methy-
lation and disease.
Disease connectivity analysis identiﬁed multiple additional diseases associated with diﬀerentially methylated
genes, including melanoma for which an etiological link with PCB exposure is established, as well as develop-
mental and neurological diseases for which there is corresponding epidemiological evidence. Diﬀerentially
methylated genes include many homeobox genes, suggesting that PCBs target stem cells. Furthermore, numerous
polycomb protein target genes were hypermethylated with increasing exposure, an eﬀect known to constitute an
early marker of carcinogenesis.
Conclusions: This study provides mechanistic evidence in support of a link between exposure to PCBs and the
etiology of CLL and underlines the utility of omic proﬁling in the evaluation of the potential toxicity of en-
vironmental chemicals.
1. Introduction
Chlorinated persistent pollutants (POPs) are a category of environ-
mental pollutants which are causing substantial health concerns (El-
Shahawi et al., 2010; Faroon and Ruiz, 2015). They include poly-
chlorinated biphenyls (PCBs), various organochlorine pesticides such as
DDT (and its breakdown product DDE) and hexachlorobenzene (HCB),
as well as numerous additional chemicals which were previously used
for industrial or agricultural purposes. Although the use of these che-
micals has ceased since many years, their resistance to degradation
results in their wide persistence in the environment, including air, soil
and water. Owing to their high lipophilicity, POPs accumulate along the
food chain, with the consequence that humans are exposed to them
primarily via the diet, especially the consumption of contaminated ﬁsh,
meat and dairy products.
Signiﬁcant experimental and epidemiological evidence suggests that
exposure to chlorinated POPs may be linked to adverse eﬀects on the
immune, endocrine, nervous and reproductive systems, developmental
eﬀects and cancer (Crinnion, 2011; Everett et al., 2011; Lind et al.,
2012; Perkins et al., 2016). In particular as regards cancer, a recent in-
depth evaluation of the epidemiological and mechanistic evidence by
the International Agency for Research on Cancer (IARC) concluded that
the evidence linking exposure to PCBs with the induction of melanoma
is suﬃcient to allow classiﬁcation of this group of chemicals as category
1 human carcinogens (IARC, 2016).
The mechanisms by which chlorinated POPs cause their toxic eﬀects
are not well understood. Most have low genotoxicity, while many in-
teract with important cellular receptors, including the Ah, estrogen and
androgen receptors, and it is possible that such interactions may be
important for these chemicals' toxicity (Mrema et al., 2013). In order to
explore the mechanistic basis of possible links between exposure to
POPs and disease, a small number of studies have examined changes in
genome-wide gene expression in peripheral blood leucocytes of exposed
humans. Thus a study on pre-pubertal girls found changes in the ex-
pression of genes linked to connective tissue, skeletal muscular and
genetic disorders as well as neurological diseases (Mitra et al., 2012),
while a more recent follow-up study (Ghosh et al., 2018) on a mixed-sex
group of similar age found gene expression changes linked to various
types of cancer, including prostate and breast cancer as well as non-
Hodgkin's lymphoma. Recently we examined the association between
exposure to a number of PCBs, HCB and DDE, a number of PCBs, HCB
and DDE, and miRNA expression proﬁles in peripheral blood leucocytes
of adults, identifying a series of expression changes related to various
types of cancer, including lung, bladder, prostate and thyroid cancer, as
well as chronic myeloid leukemia (Krauskopf et al., 2017).
Here we report the results of a genome-wide investigation of the
associations between the concentrations of 6 PCBs, DDE and HCB in
peripheral blood plasma of adult subjects without diagnosed disease
and the methylation of CpG sites in peripheral blood leucocytes, which
allowed us to characterize exposure-associated epigenetic proﬁles and
to evaluate their signiﬁcance in relation to the chemicals' toxicity. In
addition, and having in mind the contradictory epidemiological
evidence regarding the relationship between PCB exposure and risk of
B-cell lymphoma (IARC, 2016; Zani et al., 2017), we compared the
exposure-related epigenetic proﬁles with the epigenetic proﬁle in pre-
diagnostic blood leukocytes we recently found to be associated with
risk of future B-cell chronic lymphocytic leukemia (CLL) (Georgiadis
et al., 2017) as well as with an epigenetic proﬁle reported to char-
acterize clinical CLL (Kulis et al., 2012).
2. Methods
2.1. Study population
The study was conducted in the context of the European
EnviroGenomarkers project (http://www.envirogenomarkers.net/). It
involved subjects, free of diagnosed disease at recruitment, from two
population-based cohorts, the European Prospective Investigation into
Cancer and Nutrition study (EPIC-ITALY) (Bingham and Riboli, 2004)
and the Västerbotten Intervention Programme within the Northern
Sweden Health and Disease Study (Hallmans et al., 2003) (Table 1).
Standardized lifestyle and personal history questionnaires, anthropo-
metric data and frozen blood fractions, collected at recruitment
(1993–1998 for EPIC-ITALY, 1990–2006 for NSHDS), were available.
The Envirogenomarkers project was originally designed as two nested
Table 1
Study population.
Total population EPIC Italy NSHDS
All study subjects 659 251 408
Excluded from the current study
Missing data or extreme exposures 20 3 17
CLL cases 28 9 19
Included in the current study
All subjects 611 239 372
Age; mean (SD) 52.2 (7.8) 53.3 (8.1) 51.5 (7.5)
BMI; mean (SD) 25.8 (3.9) 25.8 (3.6) 25.9 (4.1)
Sex
Male (%) 215 (35.2) 59 (24.7) 156 (41.9)
Female (%) 396 (64.8) 180 (76.3) 216 (58.1)
Smoking status
Current smokers (%) 140 (22.9) 61 (25.5) 79 (21.2)
Never smokers (%) 287 (47.0) 111 (46.4) 176 (47.3)
Former smokers (%) 184 (30.1) 67 (28.0) 117 (31.5)
Health status
Controls (%) 316 (51.7) 123 (51.5) 193 (51.9)
Future cases (%) 295 (48.3) 116 (48.5) 179 (48.1)
Disease (future cases)
Breast cancer 91 46 45
BCL 204 70 134
BCL subtypes
DLBL 40 11 29
FL 32 19 13
MM 66 21 45
Other 66 19 47
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case-control studies, one for B-cell lymphoma and one for breast cancer.
No participant was diagnosed with disease within<2 years of blood
sample collection and for this reason in the context of the present study
all participants were treated as apparently healthy at recruitment. In-
cident disease cases, including B-cell lymphoma, were identiﬁed
through local Cancer Registries (loss to follow-up < 2%) and occurred
between 2 and 15.7 years after recruitment. B-cell lymphoma cases
were classiﬁed into subtypes according to the SEER ICD-0-3 mor-
phology (Fritz et al., 2000). Cases with CLL had a mean age at diagnosis
of 59.0 (43.6–75.5) years and were diagnosed 6.9 (2.0–15.5) years after
recruitment. Cases with other BCL subtypes had a similar age and time-
to-disease distribution, with a mean age at diagnosis of 58.5
(30.1–73.5) years and a time to diagnosis of 6.0 (2.0–15.9) years.
The project and its associated studies and protocols were approved
by the Regional Ethical Review Board of the Umea Division of Medical
Research, as regards the Swedish cohort, and the Florence Health Unit
Local Ethical Committee, as regards the Italian cohort, and all partici-
pants gave written informed consent. The studies were conducted in
accordance with approved guidelines.
2.2. Analytical procedures and data processing
All analytical and data processing procedures employed, including
DNA methylation and gene expression proﬁling, have been previously
described in detail (Georgiadis et al., 2016). Genome-wide analysis of
CpG methylation was conducted on the Illumina Inﬁnium Hu-
manMethylation450 platform and, after preprocessing, yielded data on
396,808 CpG sites. Methylation levels were expressed as M-values
corresponding to the logarithmic ratio of the methylated versus the
unmethylated signal intensities.
Plasma POP concentrations were measured as previously described
(Kelly et al., 2017) by a procedure involving protein precipitation with
ethanol, extraction of the POPs into dichloromethane–hexane and
analysis gas chromatography–mass spectrometry. For quality control
purposes in each batch of samples two reagent blanks were additionally
prepared and the average result of the blank samples subtracted from
the results of the real samples. Furthermore, two control samples of
Standard Reference Material 1589a (PCBs, Pesticides, BDEs, Dioxins/
Furans in Humans) from the National Institute of Standards and Tech-
nology, were also included in each batch (n=43) of samples. De-
pending on the POP, mean concentration of SRM 1589a from all sample
batches varied from 92% to 106% of certiﬁed values and co-eﬃcient of
variation from 3.8% to 10.7%.
2.3. Statistical analyses
Generalized linear models using the signals corrected for batch ef-
fects (date of chip analysis) were ran using the ArrayStudio (Omicsoft,
Cary, NC, USA, version 8.0.1.32) software package, with inclusion of
the moderated t-test (LIMMA) and ﬁltration (with multiple testing ac-
counted for using FDR Benjamini-Hochberg correction, alpha=0.05
and maximum iterations= 5).
In the statistical models for the derivation of exposure-associated
proﬁles we used M-values as dependent variables, the plasma con-
centrations of the diﬀerent POPs as the independent variable, and sex,
age, BMI, cohort, health status (control or future case) as well as the six
cell type fractions [CD4, CD8, NK cells, monocytes, B-cells, granulo-
cytes; estimated from the methylation data using a published algorithm
(Houseman et al., 2012)] as confounder variables. In some analyses
additional parameters were included in the model as confounders, as
detailed in the text. Multiple testing was accounted for by using FDR
Benjamini-Hochberg correction.
For the derivation of epigenetic proﬁles associated with future risk
of diﬀerent sub-types of B-cell lymphoma we compared the DNA me-
thylation proﬁles of subjects who later developed B-cell lymphoma and
control subjects who remained free of any disease (Table 1). In the
statistical models we used future disease status as the independent
variable and the same set of confounder variables as above unless
otherwise stated.
Following exploratory evaluations, in the statistical modelling we
adopted the plasma POP concentrations winsorised at 1% and 99% in
order to control for a small number of subjects with outlier levels of
particular POPs (see Supplemental Material, Section 1). We also ex-
plored the impact of winsorising the M-value distributions and came to
the conclusion that this was not necessary. Venn diagrams were pre-
pared using the software VennPainter (Lin et al., 2016).
2.4. Mediation analysis
Model-based causal mediation analysis was implemented using the
R package “mediation” (Tingley et al., 2014). A customized R script was
developed to iteratively construct the appropriate mediator and out-
come models for each selected CG site. Each mediator model consisted
of a linear regression ﬁt including exposure (PCB156 plasma con-
centrations), the confounder variables (sex, age, BMI, white blood cell
fraction) and using the methylation M-values of the corresponding CpG
site as the dependent variable. Similarly each outcome model com-
prised a probit regression ﬁt with both PCB156 concentrations and CpG
methylation included as independent confounder variables and using
the future case/control status as the dependent variable. During each
iteration the two constructed models were used as input for the
“mediate” R function, declaring PCB156 exposure as the treatment
variable (“treat” argument), the CpG methylation as the mediator
(“mediator” argument) and running 10,000 simulations (“sims” argu-
ment= 10,000). The ﬁnal results were ﬁltered using a p-value cutoﬀ of
0.05 for the average causal mediation eﬀects (ACME).
2.5. Bioinformatics analysis
Gene names obtained from the ArrayStudio output were checked
with the on-line HGNC (HUGO gene nomenclature committee) tool
(https://www.genenames.org/cgi-bin/symbol_ checker) and the re-
turned names were subsequently used for bioinformatics analysis.
GO term analysis and identiﬁcation of hub genes (genes linked to
multiple GO terms and therefore playing a central regulatory role) were
performed using the BioinfoMiner web application (https://
bioinfominer.com/) which, thanks to its nonparametric, empirical
prioritization approach, can be applied to classes of statistical testing
problems that deﬂect from traditional hypotheses, as is the case for
DNA methylation proﬁles. Pathway and disease connectivity analysis
were performed using the “set analyzer” tool of the Comparative
Toxicogenomic Database (http://ctd.mdibl.org), which utilizes manu-
ally curated information about chemical-gene/protein-disease re-
lationships.
3. Results
3.1. POP exposure assessment
We measured plasma POP concentrations in 659 subjects aged
29.6–74.9 years from two prospective cohorts (Table 1). For the deri-
vation of POP-related epigenetic exposure proﬁles we excluded 1 sub-
ject with outlier levels of all POP exposures and 19 subjects with
missing relevant data. We also excluded 28 subjects who later devel-
oped CLL because we have previously observed (Georgiadis et al.,
2017) that some of these subjects had major perturbations of their
epigenetic proﬁles owing to large increases in their B-cell counts (no
analogous eﬀect was seen with other B-cell lymphoma subtypes). Of the
remaining 611 subjects, 316 remained disease-free during the ob-
servation period (“controls”) while the remaining 295 were diagnosed
within 2–15.7 years of recruitment with breast cancer or diﬀerent
subtypes of B-cell lymphoma other than CLL (“future cases”).
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PCB exposures, as reﬂected in the plasma concentrations, were
broadly similar for the two cohorts and the two sexes, although small
but statistically signiﬁcant diﬀerences were observed for some con-
geners (Table 2). In contrast, the mean exposures to HCB and DDE were
substantially (roughly 3fold) higher in Italy than in Sweden. The ex-
posures to the diﬀerent PCB congeners were highly inter-correlated,
with most Spearman r values > 0.8 (slightly lower for PCB118; Table
S1 in Supplementary Text). The exposures to HCB and DDE were
moderately correlated to each other and poorly correlated to those of
PCBs.
3.2. Epigenetic exposure proﬁles
We used generalized linear models to evaluate the relationships
between the methylation of diﬀerent CpG sites and POP exposure le-
vels. Since our aim was to evaluate the impact of POP exposure, as
quantitatively reﬂected in blood-borne POP concentrations, on the
epigenetic proﬁle of white blood cells (i.e. a direct interaction between
POPs and cells, both present in blood), we employed as measures of
exposure the plasma POP concentrations (log-transformed) without
correction for lipid concentrations. In addition we have conﬁrmed that
correcting for plasma lipid concentrations did not have a major impact
on the resulting exposure proﬁles (see Supplementary Text, Section 2).
Table 3 summarises the numbers of CpG sites whose methylation
correlates, at diﬀerent statistical stringencies, with the exposure bio-
markers. It can be seen that a) large numbers of statistically signiﬁcant
signals are observed in males, especially in Sweden, and b) most hits are
associated with PCB156. Additional statistical adjustment for education
and physical activity, consumption of alcohol and energy, as well as for
exposure to DDE and HCB (both much higher in Italy), did not lead to
convergence of the cohort- or sex-stratiﬁed results (not shown).
We carried out a series of additional tests to explore possible reasons
for our failure to detect signiﬁcant signals in the Italian cohort and in
females, described in detail in Supplementary Text, Section 3. The re-
sults suggest qualitatively similar but substantially weaker responses in
the Italian cohort and in females as compared to Swedish males, at least
partly accounting for the near absence of statistically signiﬁcant signals
in these sub-groups.
Restriction of the analysis to the group of Swedish male controls, i.e.
with exclusion of 72 subjects who eventually developed diﬀerent sub-
types of B-cell lymphoma, yielded 170 signals associated with PCB156
at FDR < 0.01 as compared to 625 signals obtained without this ex-
clusion. As indicated in Fig. S2 in Supplementary Text, the two groups
show qualitatively and quantitatively closely similar responses and the
top signals in the two groups largely overlap, demonstrating absence of
any bias in the proﬁle resulting from the inclusion of case subjects.
Based on the above results, we conclude that the CpG methylation
changes observed in the group of all Swedish males reﬂect qualitatively
the eﬀects of POPs on DNA methylation regardless of location, sex or
future disease status, and for this reason the discussion which follows is
based on the results obtained in this group, unless otherwise stated.
A total of 650 CpG sites are associated at high statistical stringency
(FDR < 0.01) with exposure to at least one PCB (656 to at least one
POP) (Table 3 and Excel Supplementary Table S1), with most being
associated with PCB156 (625 sites) (Fig. 1A). The non-PCB POPs DDE
and HCB yielded a much smaller number of signiﬁcant signals, which
largely overlap with PCB-associated signals (Fig. 1B). Based on data
from the internal POP standards used in the study, the accuracy and
precision in the measurement of the diﬀerent congeners was similar and
cannot explain the preferential association of signals with PCB156.
Having also in mind the high inter-correlation of the exposure levels
(especially of PCB's), we conclude that the large number of signals
which statistically correlate with speciﬁc congeners is unlikely to reﬂect
true chemical-speciﬁc eﬀects, rather probably arising from speciﬁc
characteristics of the exposure distributions or chance. This possibility
ﬁnds support in the observation in Table 3 of substantial numbers of
signals associated with chemicals other than PCB156 when the statis-
tical stringency is relaxed to FDR0.05 (see Discussion). For this reason
further discussion is focused on signals associated with any PCB or POP.
Approximately equal numbers of CpG sites exhibit hypo- or hy-
permethylation with increasing exposure, with the mean change in
methylation per quartile of PCB156 for the top signals ranging ap-
proximately 1–15% of the average methylation value.
3.3. Bioinformatics analysis of the POP exposure proﬁle
The 656 diﬀerentially methylated CpG sites associated with at least
one POP congener are related to 439 unique genes (including 20 hub
genes; see Methods), shown in Excel Supplementary Table S2 together
with various key characteristics. The list of diﬀerentially methylated
genes includes a total of 15 homeobox genes (Zhong and Holland,
2011), all of which are hypermethylated with increasing exposure
Bioinformatic analysis yields a large number of GO terms (Excel Sup-
plementary Table S3) as well as 11 non-redundant pathway terms
(Excel Supplementary Table S4).
Another notable feature of the list of diﬀerentially methylated genes
is the presence of large numbers of polycomb group protein targets
(PcGT's), a category of genes whose promoter hypermethylation, and
consequent expression downregulation, has emerged as a hallmark of
the early stages of cancer pathogenesis (Widschwendter et al., 2018).
Thus> 25% (121) of the diﬀerentially methylated genes belong to the
class of PcGT genes (Bracken et al., 2006; Lee et al., 2006), the great
majority of which are hypermethylated with increasing exposure at all
their diﬀerentially methylated CpG sites (Excel Supplementary Table
S2). Furthermore, the majority of 45 hypermethylated PcGT genes for
which we had expression data showed a decrease in their expression
which reached statistical signiﬁcance for 5. Thus a picture emerges of
POPs targeting for hypermethylation and downregulation homeobox
and PcGT genes.
Disease connectivity analysis of the set of diﬀerentially methylated
genes yielded a total of 64 signiﬁcant non-generic terms (Excel
Supplementary Table S5) which embrace, among disease categories,
cancer (including melanoma) and diseases of the cardiovascular, ner-
vous, urogenital, respiratory tract and immune systems as well as
congenital abnormalities.
Table 2
POP exposures by cohort and sex, mean ± SD (pg/ml).
Italy Sweden p Males Females p
PCB118 213.7 ± 134.0 145.4 ± 103.9 <1×10−5 152.6 ± 116.1 182.8 ± 122.4 <1×10−5
PCB138 571.2 ± 297.5 632.3 ± 389.8 ns 653.4 ± 438.9 584.0 ± 301.0 ns
PCB153 1112.3 ± 561.7 1116.9 ± 540.6 ns 1162.4 ± 580.6 1089.4 ± 527.7 ns
PCB156 95.6 ± 48.8 101 ± 50.2 ns 107.2 ± 56.2 94.3 ± 45.1 0.0099
PCB170 351.8 ± 187.1 385 ± 198.7 0.0035 414.7 ± 226.5 348.9 ± 170.4 0.00012
PCB180 846.7 ± 477.9 721.3 ± 309.7 0.015 810.6 ± 364.9 748.5 ± 399.0 0.0035
HCB 788.3 ± 634.8 246.1 ± 127.6 <1×10−5 347.8 ± 396.6 518.2 ± 519.5 <1×10−5
DDE 7485.6 ± 5947.1 2447 ± 2331.6 <1×10−5 3551.7 ± 3964.2 4888.2 ± 5149.6 0.0002
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3.4. Comparison of POP exposure proﬁles with the proﬁle predictive of CLL
risk
We recently reported on an epigenetic proﬁle in prediagnostic blood
leucocytes which is strongly associated with future risk of CLL
(Georgiadis et al., 2017). This proﬁle includes 4295 signiﬁcantly
(FDR < 0.01) diﬀerentially methylated CpG sites and was derived
from the comparison of the epigenetic proﬁles of 28 subjects, who were
diagnosed with CLL 2–15.7 years after sample donation, with those of
319 subjects who remained free of disease, 315 of whom were included
in the present study, coming from both cohorts and both sexes. Com-
parison of this proﬁle with the POP exposure proﬁles described in
Section 3.2 reveals overlaps of upto 38 CpG sites (p=1.86×10−16),
associated with 30 genes, a “meet-in-the-middle” (MITM) epigenetic
proﬁle which potentially represents a mechanistic link between ex-
posure and disease (Tables 4 and 5). Importantly, for all MITM signals,
the eﬀects on methylation of a) increasing exposure and b) future CLL
case status are in the same direction (Table 5), making the probability
of a chance ﬁnding even more remote and strongly enhancing the
biological signiﬁcance of this overlap.
We carried out a series of additional tests to check the stability of
the above MITM proﬁle (Table4):
a) Comparison of the PCB156 exposure proﬁle obtained in all males,
rather than only Swedish males, with the CLL risk proﬁles obtained
in all subjects or in all males, gave smaller but statistically highly
signiﬁcant MITM proﬁles which largely overlap with the one de-
scribed above.
b) Use of the CLL risk proﬁle obtained with additional adjustment for
the level of exposure to PCB156 (to correct for any confounding by
this or a correlated parameter) did not substantially change the re-
sulting MITM proﬁle, while adjustment of the exposure proﬁle for
education and physical activity yielded a smaller but signiﬁcant and
largely overlapping MITM.
Table 3
Number of CpGs associated with exposure to diﬀerent POPs, at diﬀerent statistical stringencies.
Exposure Statistical signiﬁcance Mixed cohorts Italy Sweden
All Males Females All Males Females All Males Females
PCB118 Bonferroni p < 0.05 1 0 0 0 0 0 5 6 0
FDR < 0.01 0 0 0 0 0 0 7 5 0
FDR < 0.05 1 12 0 0 0 0 493 89 0
PCB138 Bonferroni p < 0.05 0 5 0 0 0 0 3 2 0
FDR < 0.01 0 10 0 0 0 0 0 2 0
FDR < 0.05 0 226 0 0 0 0 52 238 0
PCB153 Bonferroni p < 0.05 1 10 1 0 1 0 1 6 0
FDR < 0.01 1 39 0 0 0 0 7 26 0
FDR < 0.05 1 1303 1 0 56 0 220 1832 0
PCB156 Bonferroni p < 0.05 1 14 1 0 2 1 2 14 0
FDR < 0.01 1 192 0 0 0 1 0 625 0
FDR < 0.05 3 4606 1 2 33 2 6 7766 0
PCB170 Bonferroni p < 0.05 1 11 0 0 0 1 2 6 0
FDR < 0.01 0 21 0 0 0 0 0 115 0
FDR < 0.05 1 895 0 0 0 2 7 3117 0
PCB180 Bonferroni p < 0.05 2 5 0 0 0 0 0 4 0
FDR < 0.01 0 6 0 0 0 0 0 29 0
FDR < 0.05 2 301 0 3 0 0 4 2383 0
DDE Bonferroni p < 0.05 0 0 0 0 0 0 4 7 0
FDR < 0.01 0 0 0 0 0 0 3 10 0
FDR < 0.05 0 0 0 0 0 0 267 213 0
HCB Bonferroni p < 0.05 0 1 0 0 0 0 7 4 0
FDR < 0.01 0 0 0 0 0 0 10 4 0
FDR < 0.05 0 3 0 0 0 0 808 659 76
Fig. 1. Venn diagrams illustrating the overlaps between diﬀerent PCBs (A) and PCBs and the two non-PCB POPs studies (B). Six hundred twenty ﬁve signals are
associated with PCB156, of which 526 are associated exclusively with this exposure, followed by PCB170 (115, of which 16 are associated exclusively with this
exposure).
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c) Using the PCB156 exposure proﬁle obtained in Swedish male con-
trols (i.e. with the exclusion of all future cases of B-cell lymphoma)
yielded a smaller but statistically signiﬁcant MITM which largely
overlaps with that observed without this exclusion. d) Finally, use of
the CLL risk proﬁle derived using only Swedish male subjects,
without or with additional adjustment for PCB156, resulted in
smaller but still statistically highly signiﬁcant MITM overlaps.
3.5. Biological relevance of the MITM proﬁle
Independent evidence in support of the relevance of the observed
MITM proﬁles to the pathogenesis of CLL comes from the comparison
its 38 CpG sites (MITM for exposure to any POP) with 33,653 sites
whose methylation status has been reported to distinguish clinical CLL
from normal B-cells (Kulis et al., 2012). This reveals an overlap of 28
sites (p=1.98×10−22), for all of which the methylation changes in
the same direction with increasing exposure and in clinical CLL
(Table 5).
Additional features of the MITM proﬁle shown in Table 5 include
the presence of a) 4 CpG sites which we previously found to be sig-
niﬁcant in the risk proﬁle of CLL cases who were diagnosed with the
disease> 7.3 years after sample donation (Georgiadis et al., 2017), b)
10 MITM genes which are among 168 genes we previously reported to
be targeted for extensive epigenetic modiﬁcation in future CLL case
subjects, and c) a number of genes which play hub gene roles in the CLL
risk or/and the POP exposure proﬁles. Finally, the MITM proﬁle in-
cludes 4 homeobox genes and 18 polycomb group protein target genes,
with most of the latter being hypermethylated with increasing exposure
at multiple CpG sites within the same CpG islands (coeﬃcient > 0 and
hypergeometric p < 0.05 in Excel Supplementary Table S6).
3.6. Mediation analysis
We conducted mediation analysis to evaluate the relationship be-
tween exposure to PCB156, future CLL case status and CpG methylation
in Swedish males, using the 5 MITM CpG sites with highest statistical
association (Bonferroni-corrected p < 0.05) with exposure to PCB156
or CLL risk. As shown in Table 6, signiﬁcant mediation was found for 3
of these sites, although no statistically signiﬁcant direct or total eﬀect
was observed. The absence of a signiﬁcant total eﬀect (direct associa-
tion between POP exposure and CLL risk) is in agreement with our
previously reported ﬁndings (Kelly et al., 2017) based on the full set of
CLL cases of the Envirogenomarkers project (42 subjects), from which
the subjects of the present study were drawn, as well as an analogous
analysis based only on the cases included in the epigenetics dataset (see
Supplementary Text, Section 5).
3.7. Other types of B-cell lymphoma
Comparison of the epigenetic proﬁles of future cases for the com-
monest lymphoma subtypes in our study with those of controls
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Table 6
Mediation analysis of the association between exposure to PCB156, DNA me-
thylation and CLL risk.
MITM site ACME (average
causal mediation
eﬀects)
ADE (average direct
eﬀects)
Total eﬀect
Estimate p Estimate p Estimate p
cg03865667 0.108 0.0052 −0.0943 0.37 0.0140 0.71
cg15912800 0.0015 0.0080 0.0010 0.67 0.00246 0.31
cg25026529 0.0462 0.012 −0.0176 0.90 0.0286 0.45
cg03007522 0.0088 0.085 8.04× 10−3 0.98 1.68× 10−2 0.68
cg00352652 0.0086 0.140 0.0120 0.42 0.0206 0.17
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(Table 1) yielded risk proﬁles consisting of 1–3 CpG sites signiﬁcant at
FDR < 0.05 (Table 7), with no overlap between them or with the POP
exposure proﬁles.
4. Discussion
4.1. POP exposure-associated changes in blood leucocyte DNA methylation
In this, the largest epigenome-wide study to-date of the relationship
between POP exposure and DNA methylation in peripheral blood leu-
cocytes, we found that in males the methylation of large numbers of
CpG sites is strongly associated with the plasma concentrations of at
least one of 6 PCB congeners, DDE and HCB, the eﬀect being strongest
in Swedish males. While no statistically signiﬁcant correlations were
observed in a smaller group of Italian males or in females at either
location, in these groups the response to exposure of the sites signiﬁcant
in Swedish males was qualitative highly similar to, but quantitatively 3-
5fold smaller than that seen in the latter group, indicating diﬀerential
sex- and location- related susceptibilities. A higher male susceptibility
to POPs has been previously reported in relation to blood leucocyte
LINE-1 DNA methylation (Lee et al., 2017), as well as in relation to a
number of developmental eﬀects (Hertz-Picciotto et al., 2005; Kishi
et al., 2013; Sonneborn et al., 2008). Such sex-speciﬁc responses may
result from the well-known interaction of POPs with key nuclear re-
ceptors, including the androgen and estrogen receptors (Bonefeld-
Jørgensen et al., 2001; Zhang and Ho, 2011). The reason for the lower
susceptibility of the Italian cohort is not known. The levels of exposure
of the two cohorts to PCBs were generally similar (Table 2), while we
have no evidence that the relative contribution of the routes of ex-
posure for the general population (mainly ingestion) (IARC, 2016)
diﬀered substantially. We conclude that untested environmental or
genetic factors may be responsible for the lower susceptibility of the
Italian subjects.
The great majority of signiﬁcant CpG sites were associated with
exposure to PCBs, especially PCB156 (Fig. 1, Table 3). Given the strong
inter-correlation of exposure to diﬀerent PCB congeners (Table S1 in
Supplementary Text), such apparently high chemical speciﬁcity is likely
to be primarily related to the high statistical stringency employed and
the exact exposure distribution or measurement error of the particular
chemical, although the possibility that this particular PCB congener
may possess a higher potency for altering DNA methylation cannot be
excluded. PCB156 (2,3,4,5,3′,4′-hexachlorobiphenyl) is a mono-ortho
PCB with signiﬁcant but low dioxin-like activity (IARC, 2016). In a
study conducted in Iceland Inuit with high POP exposures, PCB156
showed, among the PCBs examined by us, the highest association with
the methylation of Alu repetitive DNA elements in blood cells (Rusiecki
et al., 2008), although other studies also using global measures of DNA
methylation gave mixed results (Itoh et al., 2014; Kim et al., 2010; Lind
et al., 2013). In the only epigenome-wide evaluation of the eﬀects of
PCBs reported to-date (van den Dungen et al., 2017), conducted among
34 Danish males, no formally statistically signiﬁcant associations of
site-speciﬁc CpG methylation in blood leucocytes were found, while, of
8 diﬀerentially methylated regions identiﬁed, 4 included CpG sites
whose methylation we found to correlate moderately
(FDR=0.025–0.075) with PCB exposure.
4.2. PCB-induced epigenetic changes in genes controlling the fate of stem
cells
Among the CpG sites exhibiting strongest responses to PCB exposure
(large absolute coeﬃcient values; Excel Supplementary Table S1) are
sites associated with many genes related to diﬀerentiation and devel-
opment [e.g. ZFPM1 (zinc ﬁnger protein, FOG family member 1), ery-
throid and megakaryocytic cell diﬀerentiation; RDH10 (retinol dehy-
drogenase 10), organ development; TERT (telomerase reverse
transcriptase), an antiapoptotic gene and modulator of Wnt signaling].
The importance of the modulation of the epigenetic status of develop-
mental genes is particularly underlined by the large number of
homeobox genes aﬀected (15 of 439 diﬀerentially methylated genes)
(Excel Supplementary Table S2). Homeobox genes act as master reg-
ulators in the renewal and fate of stem cells (Seifert et al., 2015), while
their altered methylation is associated with cancer pathogenesis
(Rodrigues et al., 2016). Therefore modulation of their epigenetic status
by PCBs implies potential eﬀects on development and carcinogenesis.
Thus, among the diﬀerentially methylated hub homeobox genes are
HHEX (hematopoietically expressed homeobox) and PAX6 (paired box
6), involved in hematopoietic (Migueles et al., 2017) and neural tissue
diﬀerentiation (Huettl et al., 2016), respectively, WNT5A (Wnt family
member 5A) which regulates pathways related to development, in-
ﬂammation and cancer (Andersson et al., 2013; Endo et al., 2015;
Pashirzad et al., 2017), HOXA9 (homeobox A9) and PBX1 (PBX
homeobox 1), associated with myeloid leukemia/myelodysplastic syn-
drome and pre-B-cell acute lymphoblastic leukemia, respectively
(Collins and Hess, 2016; Duque-Afonso et al., 2016), as well as RBP4
(retinol binding protein 4), RDH10 (retinol dehydrogenase 10) and
ALDH1A2 (aldehyde dehydrogenase 1 family member A2), all involved
in the biosynthesis of retinoic acid, an important signaling molecule in
developing and adult tissues (Cañete et al., 2017).
The impact of exposure on stem cells is highlighted by the results of
functional analysis (Excel Supplementary Tables S3 and S4) which
yields multiple GO terms related to development, especially neurode-
velopment, and perturbed pathways related to neurotrophins, a family
of proteins which control the development and function of neuronal
cells (Huang and Reichardt, 2001). Exposure to chlorinated POPs is
well known to be associated with multiple eﬀects on the nervous
system, including neurological impairments (cognitive and peripheral
nervous system eﬀects, motor and sensory deﬁcits) and neurodegen-
erative diseases [(Alzheimer's and Parkinson's disease, amyotrophic
lateral sclerosis) in adults and neurodevelopmental diseases (autism,
attention deﬁcit, mental retardation, hearing loss) in children of ex-
posed mothers (Zeliger, 2013)]. Recent evaluations of evidence from
experimental and epidemiological studies support the suggestion that
epigenetic changes induced by environmental exposures may mediate
neurodevelopmental toxicity (Tran and Miyake, 2017).
Among the factors which determine the fate of stem cells are
polycomb proteins, which transiently repress the expression of diﬀer-
entiation-promoting genes by binding to their promoters in the form of
polycomb-repressive complexes (Mozgova and Hennig, 2015). During
recent years strong evidence has accumulated indicating that, during
the early stages of the pathogenesis of many types of cancer, including
lymphomagenesis (Wang et al., 2015), the promoters of such
Table 7
Epigenetic risk proﬁles for diﬀerent BCL subtypes.
Lymphoma subtypes CpG FDR Raw pa Coeﬃcient Gene Gene name
Multiple myeloma cg00036110 0.033 8.19× 10−8 0.192 HPCAL4 Hippocalcin like 4
DLBL cg10309377 0.038 9.68× 10−8 −0.229
Follicular lymphoma cg13267776 0.012 4.58× 10−8 −0.434 CNNM2 Cyclin and CBS domain divalent metal cation transport mediator 2
cg09851981 0.012 6.32× 10−8 0.506 GOLGB1 Golgin B1
cg06785701 0.012 8.92× 10−8 −0.540 LOC407835 Mitogen-activated protein kinase kinase 2 pseudogene
a Bonferroni-corrected p < 0.05 corresponds to raw p < 1.26× 10−7.
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prolycomb group protein target (PcGT) genes become methylated, and
hence silenced, independently of the binding of such complexes, thus
locking the cells in an undiﬀerentiated state which predisposes them to
malignant transformation (Martin-Perez et al., 2010; Widschwendter
et al., 2007). Based on these observations it has been proposed that
methylation of PcGT genes is an early hallmark of cancer (Teschendorﬀ
et al., 2010; Widschwendter et al., 2018). In the present study we found
that a large fraction (121 out of 439) of genes diﬀerentially methylated
in association with exposure to POPs belongs to the class of PcGTs
(Excel Supplementary Table S2). The majority of these genes were
hypermethylated with increasing exposure at multiple sites within CpG
islands (Excel Supplementary Table S6), while 5 of them were sig-
niﬁcantly underexpressed, supporting the idea that POP exposure
modiﬁes cellular pathways involved in the early stages of carcinogen-
esis.
4.3. POP-induced epigenetic proﬁle and disease
We have previously shown that omic proﬁles observed in peripheral
blood leucocytes of healthy smokers predict with remarkable eﬃciency
diseases caused by tobacco smoking (Georgiadis et al., 2016), sug-
gesting that such proﬁling has the potential of identifying disease-re-
lated perturbations caused by toxic exposures. This potential is further
supported by the results of disease connectivity analysis using our list of
POP-related diﬀerentially methylated genes, which identiﬁed mela-
noma as being linked to this exposure (Excel Supplementary Table S5),
in accordance with the conclusions of an IARC evaluation (IARC, 2016).
Additional diseases suggested by our disease connectivity analysis in-
clude a number of diseases for which there is some supportive epide-
miological evidence, including breast cancer (IARC, 2016) as well as
diseases of the cardiovascular (Bergkvist et al., 2016; Kippler et al.,
2016), digestive (Deierlein et al., 2017) and endocrine (Zong et al.,
2018) systems. Furthermore, in agreement with the preceding discus-
sion regarding eﬀects on stem cells, numerous terms related to devel-
opmental and nervous system diseases and cancer are obtained.
4.4. Overlap of epigenetic proﬁles associated with PCB exposure and CLL
risk
A recent in-depth evaluation concluded that, despite epidemiolo-
gical and mechanistic data supporting a link between PCB exposure and
risk of non-Hodgkin lymphoma (NHL), a deﬁnitive conclusion of posi-
tive association cannot be drawn (IARC, 2016). Other recent meta-
analyses of the epidemiological data found no strong evidence that
exposure to PCB increases the risk of NHL (Zani et al., 2017) and a
signiﬁcant positive association of exposure to DDE and HCB with risk of
non-Hodgkin lymphoma (Luo et al., 2016).
We recently reported non-signiﬁcant, positive associations between
the plasma concentrations of most of the POP congeners examined in
the present study and future risk of CLL and follicular lymphoma [see
Kelly et al., 2017 as well as additional analyses in Supplementary Text,
Section 5]. In striking similarity with the results of the present study,
these associations were substantially stronger in males and in the
Swedish cohort. In the current study we explored further the possible
links between POP exposure and risk of B-cell lymphoma by comparing
the epigenetic proﬁles associated with exposure to those associated
with disease risk. The major ﬁnding of this exploration is the discovery
of a large, statistically highly signiﬁcant, overlap between the proﬁle
associated with the risk of future CLL and the proﬁles associated with
exposure to any POP (38 MITM CpG sites; 37 sites for any PCB), with
the direction of change of methylation in all cases being the same in
subjects who ultimately developed CLL and in subjects with higher
exposure (Table 5). The plausibility of this MITM proﬁle is further
enhanced by the fact that the CLL risk proﬁle had been derived using an
independent set of CLL case subjects, its stability to adjustment of the
CLL risk proﬁle for exposure to PCB156 and the observation of a smaller
but statistically signiﬁcant and partly overlapping MITM proﬁles using
the exposure proﬁle of control subjects alone (Table 4).
4.5. Biological plausibility of the MITM proﬁle
Twenty eight of the 38 MITM CpG sites have been reported to be
diﬀerentially methylated in clinical CLL relative to normal B-cells (Kulis
et al., 2012), with the direction of methylation.
change in CLL being the same as observed in subjects with higher
exposure for all 28 sites. This implies that the methylation changes
induced at these sites by exposure occur early during disease patho-
genesis or are present in clones of pre-clinical CLL-like cells, and are
retained all the way to full clinical disease. It is noted that, in the study
of Georgiadis et al. (2017) which identiﬁed the prediagnostic CLL risk
proﬁle employed in the present study, a progressive series of DNA
methylation and gene expression changes in white blood cells of future
CLL cases was identiﬁed, compatible with the presence in prediagnostic
blood of CLL-like cells at diﬀerent stages of progression towards clinical
disease. That the DNA methylation changes associated with the MITM
probably represent early perturbations on the disease pathogenesis
pathway, rather than being present in latent CLL clones, is supported by
the fact that 4 of the MITM CpGs (including 2 altered also in clinical
CLL) are signiﬁcant in CLL cases who were diagnosed with the dis-
ease> 7.3 years after sample donation (Georgiadis et al., 2017)
(Table 5).
The biological plausibility of the MITM proﬁle is further strength-
ened by the presence of 18 PcGT genes, most being diﬀerentially hy-
permethylated with increasing exposure, in line with the recognized
signiﬁcance of the hypermethylation of PcGT genes in carcinogenesis
(Teschendorﬀ et al., 2010; Widschwendter et al., 2018). Finally, a
number of MITM genes have been implicated in the mechanism of
carcinogenesis in B-cells. For example, BCL11a (B cell CLL/lymphoma
11A) is overexpressed in CLL, where it acts as an oncogene (Satterwhite
et al., 2001) and protects CLL cells against apoptosis (Gao et al., 2013).
LATS2 (large tumor suppressor kinase 2) is a tumor suppressor and has
been found to be underexpressed in CLL (Ouillette et al., 2008). TLR5
(toll like receptor 5) plays a critical role in B-cell homeostasis and has
been found to be mutated in CLL (Martínez-Trillos et al., 2014). Finally,
MIR196B regulates a number of genes involved in B-cell diﬀerentiation
and/or CLL, including the oncogene c-MYC (Pozzo et al., 2017), the
anti-apoptotic gene BCL2 (Vogler et al., 2017) and the homeobox gene
HOXA9 (Gwin et al., 2010).
It is also noted that 3 of 5 homeobox and PcGT genes (HOXA9, PAX6
and NOTCH4), which are hypermethylated and underexpressed at
higher exposures, while not in the MITM proﬁle, are known to be in-
volved in lymphomagenesis (Collins and Hess, 2016). Finally, exposure
is associated with the perturbation of multiple pathways related neu-
rotrophin signaling which, in addition to its importance in determining
the fate of neuronal cells, also plays an important role in carcinogenesis
[including B-cell-related cancer (Hillis et al., 2016)], especially in re-
lation to the control of cancer cell stemness.
4.6. Mediation analysis and possible causal links between POP exposure,
DNA methylation and CLL risk
Α statistically signiﬁcant mediation eﬀect between exposure to
PCB156 and disease risk was found for 3 of the 5 MITM CpG sites most
signiﬁcantly associated with exposure or disease risk (Table 6). The
involvement of these sites in the pathogenesis of CLL is biologically
plausible since they are associated with PCDH17 [protocadherin 17, a
tumor suppressor gene (Yin et al., 2016)], miR196B [hypermethylated
in leukemia, thus allowing the upregulation of a number of oncogenes
(Liu et al., 2013)] and BARHL2 [BarH like homeobox 2, hypermethy-
lated in multiple cancer types (Rauch et al., 2012) and a regulator of
proliferation and survival (Juraver-Geslin et al., 2011)]. Given this
biological plausibility, the absence of a statistically signiﬁcant total
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eﬀect probably reﬂects study size limitations, in combination with a
temporally distal relationship between exposure and disease (in our
case 2–15.7 years) (Hayes, 2009), demonstrating the potential of epi-
genetics-based intermediate biomarkers in the investigation of ex-
posure-disease risk associations.
4.7. Risk proﬁles of other subtypes of B-cell lymphoma
The number of epigenetic signals found to be associated with the
risk of future MM, DLBL or FL is very much smaller than that associated
with risk of CLL (Table 7). It is likely that this diﬀerence reﬂects, at least
to some extent, the accumulation of large clones of pre-CLL cells in
future CLL case subjects before they are diagnosed with this indolent
disease. The few signiﬁcant signals observed with the other lymphoma
subtypes do not overlap with the epigenetic proﬁle of POP exposure and
therefore do not allow any evaluation of the possible association of this
exposure with disease risk. Two studies of CpG methylation in clinical
samples of follicular lymphoma, using early versions of microarrays, do
not allow comparison with our lists (Killian et al., 2009; O'Riain et al.,
2009), while a list of 794 CpG sites diﬀerentially hypermethylated in
multiple myeloma (Agirre et al., 2015) does not include the CpG site we
found to be associated with risk of this disease. Finally, there is no
reported association of any of the genes of Table 7 with any subtype of
B-cell lymphoma, although GOLGB1 has been reported to be involved
in chromosomal mutations in hematologic neoplasias (Troadec et al.,
2017).
4.8. Conclusions
The present study reveals an extensive and biologically plausible
overlap between changes in DNA methylation induced by PCB exposure
in subjects without diagnosed disease and corresponding changes in
prediagnostic blood of subjects who later developed CLL as well as in
clinical CLL. The preponderance in the epigenetic proﬁle of PCB ex-
posure of changes in homeobox and polycomb group target genes im-
plies that stem cells may constitute critical targets of these pollutants in
relation to their toxicity.
The main limitation of our study lies in our inability to directly
replicate in the Italian cohort the eﬀects of PCBs observed in Swedish
males, probably owing to the small size of the corresponding popula-
tion. Another shortcoming relates to the lack of information on the
clinical state of the CLL cases at diagnosis, which limits our ability to
characterize the CLL risk proﬁle in relation to the possible presence of
disease at the prediagnostic stage. However, despite these short-
comings, overall our study adds to the weight of the evidence linking
exposure to PCBs with the etiology of CLL. In addition our results un-
derline the utility of blood-based proﬁling for the evaluation of the
potential toxicity of environmental chemicals.
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